Application Health and Innovation Thought Leader Delegation till Singapore, 19-21 November 2024

Purpose and goal:

Neogap Therapeutics AB creates ground-breaking treatment for cancer with minimal side effects. The treatment is personalized and is created in the following sequence: 1) biopsy tumor and normal tissue 2) identify immunogenic neoantigens with proprietary software 3) produce neoantigen 4) tumor train the patient´s own cells through neoantigen stimulation in cell culture 5) cell transfusion of activated tumor-trained T cells.

The purpose is to make Neogap known and the goal is to find partners.

Expected results and effects:

Neogap is not currently present in Asia. The trip can lead to collaborations that strengthen Neogap and, in the long run, create the conditions for an establishment in this market.

Approach and implementation:

Currently there is no plan, but the attitude is to see and learn what Singapore has to offer and be open to collaboration invitations.